{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:24Z","timestamp":1792759464753,"version":"4.5.0"},"reference-count":4,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,6,12]]},"abstract":"<jats:p>We present a case of a 30-year-old woman who suffered a central retinal artery occlusion while taking tranexamic acid. She had no vascular risk factors and was placed on the drug for treatment of menorrhagia. After 1\u2009month of taking the drug, she suffered a central retinal artery occlusion in her left eye. Tranexamic acid was discontinued to prevent vision loss in the following eye. She remains with no perception of light vision in the affected eye.<\/jats:p>","DOI":"10.1136\/bcr-2016-218246","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T03:10:23Z","timestamp":1499915423000},"page":"bcr-2016-218246","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Central retinal artery occlusion in a 30-year-old woman taking tranexamic acid"],"prefix":"10.1136","volume":"2017","author":[{"given":"Sidath","family":"Wijetilleka","sequence":"first","affiliation":[{"name":"Cardiff Eye Unit, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien Chia Ming","family":"Yeo","sequence":"additional","affiliation":[{"name":"Cardiff Eye Unit, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Sharma","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Singleton Hospital, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"2025082800392872000_2017.jul12_1.bcr-2016-218246.1","unstructured":"19th WHO Model List of Essential Medicines: WHO, 2015."},{"key":"2025082800392872000_2017.jul12_1.bcr-2016-218246.2","unstructured":"Agarwal A . Gass atlas of macular diseases. 5th ed. Elsevier, 2012."},{"key":"2025082800392872000_2017.jul12_1.bcr-2016-218246.3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0002-9394(88)90069-4","article-title":"Retinal artery occlusion associated with tranexamic acid therapy","volume":"105","author":"Parsons","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"2025082800392872000_2017.jul12_1.bcr-2016-218246.4","first-page":"7851996","article-title":"Central retinal artery occlusion related to ingestion of tranexamic acid","volume":"19","author":"Dighiero","year":"1996","journal-title":"J Fr Ophtalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-218246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:39:37Z","timestamp":1756366777000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-218246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":4,"alternative-id":["10.1136\/bcr-2016-218246"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-218246","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]}}}